Literature DB >> 18759836

Related causal frameworks for surrogate outcomes.

Marshall M Joffe1, Tom Greene.   

Abstract

SUMMARY: Four major frameworks have been developed for evaluating surrogate markers in randomized trials: one based on conditional independence of observable variables, another based on direct and indirect effects, a third based on a meta-analysis, and a fourth based on principal stratification. The first two of these fit into a paradigm we call the causal-effects (CE) paradigm, in which, for a good surrogate, the effect of treatment on the surrogate, combined with the effect of the surrogate on the clinical outcome, allow prediction of the effect of the treatment on the clinical outcome. The last two approaches fall into the causal-association (CA) paradigm, in which the effect of the treatment on the surrogate is associated with its effect on the clinical outcome. We consider the CE paradigm first, and consider identifying assumptions and some simple estimation procedures; we then consider the CA paradigm. We examine the relationships among these approaches and associated estimators. We perform a small simulation study to illustrate properties of the various estimators under different scenarios, and conclude with a discussion of the applicability of both paradigms.

Mesh:

Substances:

Year:  2009        PMID: 18759836     DOI: 10.1111/j.1541-0420.2008.01106.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  49 in total

1.  Comparing biomarkers as principal surrogate endpoints.

Authors:  Ying Huang; Peter B Gilbert
Journal:  Biometrics       Date:  2011-04-22       Impact factor: 2.571

2.  Commentary on "Principal stratification - a goal or a tool?" by Judea Pearl.

Authors:  Peter B Gilbert; Michael G Hudgens; Julian Wolfson
Journal:  Int J Biostat       Date:  2011-09-20       Impact factor: 0.968

3.  Principal stratification and attribution prohibition: good ideas taken too far.

Authors:  Marshall Joffe
Journal:  Int J Biostat       Date:  2011-09-14       Impact factor: 0.968

4.  A unified procedure for meta-analytic evaluation of surrogate end points in randomized clinical trials.

Authors:  James Y Dai; James P Hughes
Journal:  Biostatistics       Date:  2012-03-06       Impact factor: 5.899

5.  Evaluating principal surrogate endpoints with time-to-event data accounting for time-varying treatment efficacy.

Authors:  Erin E Gabriel; Peter B Gilbert
Journal:  Biostatistics       Date:  2013-12-13       Impact factor: 5.899

6.  A causal framework for surrogate endpoints with semi-competing risks data.

Authors:  Debashis Ghosh
Journal:  Stat Probab Lett       Date:  2012-06-16       Impact factor: 0.870

7.  Estimation of the optimal surrogate based on a randomized trial.

Authors:  Brenda L Price; Peter B Gilbert; Mark J van der Laan
Journal:  Biometrics       Date:  2018-04-27       Impact factor: 2.571

8.  Exploring causality mechanism in the joint analysis of longitudinal and survival data.

Authors:  Lei Liu; Cheng Zheng; Joseph Kang
Journal:  Stat Med       Date:  2018-06-07       Impact factor: 2.373

9.  Bayesian inference for causal mediation effects using principal stratification with dichotomous mediators and outcomes.

Authors:  Michael R Elliott; Trivellore E Raghunathan; Yun Li
Journal:  Biostatistics       Date:  2010-01-25       Impact factor: 5.899

Review 10.  Principal stratification--a goal or a tool?

Authors:  Judea Pearl
Journal:  Int J Biostat       Date:  2011-03-30       Impact factor: 0.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.